UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 33

Sortiert nach

Patient preference for once-weekly alendronate 70 mg versus once-daily alendronate 10 mg: A multicenter, randomized, open-label, crossover study

Clinical therapeutics, 2002-11, Vol.24 (11), p.1871-1886

2002

Link zum Volltext

Verfügbarkeit prüfen

Once-weekly alendronate 70 mg and raloxifene 60 mg daily in the treatment of postmenopausal osteoporosis

Menopause (New York, N.Y.), 2004-07, Vol.11 (4), p.405-415

2004

Link zum Volltext

Verfügbarkeit prüfen

Dose-comparison study of the combination of ezetimibe and simvastatin (Vytorin) versus atorvastatin in patients with hypercholesterolemia: The Vytorin Versus Atorvastatin (VYVA) Study

The American heart journal, 2005-03, Vol.149 (3), p.464-473

2005

Link zum Volltext

Verfügbarkeit prüfen

Early intensive vs a delayed conservative simvastatin strategy in patients with acute coronary syndromes: phase Z of the A to Z trial

JAMA : the journal of the American Medical Association, 2004-09, Vol.292 (11), p.1307

2004

Link zum Volltext

Verfügbarkeit prüfen

Effectiveness and tolerability of simvastatin plus fenofibrate for combined hyperlipidemia (the SAFARI trial)

The American journal of cardiology, 2005-02, Vol.95 (4), p.462-468

2005

Link zum Volltext

Verfügbarkeit prüfen

Rechallenge of patients who had discontinued alendronate therapy because of upper gastrointestinal symptoms

Clinical therapeutics, 2000-12, Vol.22 (12), p.1433-1442

2000

Link zum Volltext

Verfügbarkeit prüfen

Efficacy and safety of ezetimibe co-administered with simvastatin compared with atorvastatin in adults with hypercholesterolemia

The American journal of cardiology, 2004-06, Vol.93 (12), p.1487-1494

2004

Link zum Volltext

Verfügbarkeit prüfen

Effectiveness of the addition of ezetimibe to ongoing statin therapy in modifying lipid profiles and attaining low-density lipoprotein cholesterol goals in older and elderly patients: Subanalyses of data from a randomized, double-blind, placebo-controlled trial

The American journal of geriatric pharmacotherapy, 2005-12, Vol.3 (4), p.218-228

2005

Link zum Volltext

Verfügbarkeit prüfen

Safety and efficacy of enoxaparin vs unfractionated heparin in patients with non-ST-segment elevation acute coronary syndromes who receive tirofiban and aspirin: a randomized controlled trial

JAMA : the journal of the American Medical Association, 2004-07, Vol.292 (1), p.55

2004

Link zum Volltext

Verfügbarkeit prüfen

Sequence variation in NPC1L1 and association with improved LDL-cholesterol lowering in response to ezetimibe treatment

Genomics (San Diego, Calif.), 2005-12, Vol.86 (6), p.648-656

2005

Link zum Volltext

Verfügbarkeit prüfen

Lipid altering-efficacy of ezetimibe co-administered with simvastatin compared with rosuvastatin: a meta-analysis of pooled data from 14 clinical trials

Current medical research and opinion, 2005-07, Vol.21 (7), p.1123-1130

2005

Link zum Volltext

Verfügbarkeit prüfen

The rechallenge of patients who previously discontinued alendronate due to upper gastrointestinal symptoms

The American journal of gastroenterology, 2000-09, Vol.95 (9), p.2457-2457

2000

Link zum Volltext

Verfügbarkeit prüfen

Effect on high-density lipoprotein cholesterol of maximum dose simvastatin and atorvastatin in patients with hypercholesterolemia: Results of the Comparative HDL Efficacy and Safety Study (CHESS)

The American heart journal, 2003-11, Vol.146 (5), p.862-869

2003

Link zum Volltext

Verfügbarkeit prüfen

Enoxaparin versus unfractionated heparin in patients treated with tirofiban, aspirin and an early conservative initial management strategy: results from the A phase of the A-to-Z trial

European heart journal, 2004-10, Vol.25 (19), p.1688-1694

2004

Link zum Volltext

Verfügbarkeit prüfen

Dyslipidemia in Patients with Type 2 Diabetes. Relationships between Lipids, Kidney Disease and Cardiovascular Disease

Clinical chemistry and laboratory medicine, 2003-09, Vol.41 (9), p.1174-1181

2003

Link zum Volltext

Verfügbarkeit prüfen

Efficacy and tolerability of finasteride 1 mg in men aged 41 to 60 years with male pattern hair loss

EJD. European journal of dermatology, 2003-03, Vol.13 (2), p.150-160

2003

Link zum Volltext

Verfügbarkeit prüfen

Ezetimibe/Simvastatin Versus Atorvastatin for Patients Who Have Diabetes Mellitus and Hypercholesterolemia

Diabetes (New York, N.Y.), 2005-06, Vol.54, p.A235

2005

Link zum Volltext

Verfügbarkeit prüfen

A multicenter, randomized, double-blind clinical trial comparing the low-density lipoprotein cholesterol-lowering ability of lovastatin 10, 20, and 40 mg/d with fluvastatin 20 and 40 mg/d

Clinical therapeutics, 2003-11, Vol.25 (11), p.2738-2753

2003

Link zum Volltext

Verfügbarkeit prüfen

1084-176 Efficacy of ezetimibe coadministered with simvastatin versus atorvastatin in patients with hypercholesterolemia

Journal of the American College of Cardiology, 2004-03, Vol.43 (5), p.A480-A481

2004

Link zum Volltext

Verfügbarkeit prüfen

Effectiveness of simvastatin therapy in raising HDL-C in patients with type 2 diabetes and low HDL-C

Current medical research and opinion, 2004-07, Vol.20 (7), p.1087-1094

2004

Link zum Volltext

Verfügbarkeit prüfen

Hyperfiltration in African-American patients with type 2 diabetes. Cross-sectional and longitudinal data

Diabetes care, 1998-12, Vol.21 (12), p.2129

1998

Link zum Volltext

Verfügbarkeit prüfen

Dyslipidemia in patients with type 2 diabetes. Relationships between lipids, kidney disease and cardiovascular disease: Diabetes mellitus

Clinical chemistry and laboratory medicine, 2003, Vol.41 (9), p.1174-1181

2003

Link zum Volltext

Verfügbarkeit prüfen

861-2 Enoxaparin versus unfractionated heparin in patients treated with tirofiban, aspirin, and an early conservation initial management strategy: Results from the A phase of the A to Z trial

Journal of the American College of Cardiology, 2004-03, Vol.43 (5), p.A302-A302

2004

Link zum Volltext

Verfügbarkeit prüfen

The rechallenge of patients who previously discontinued alendronate due to upper gastrointestinal symptoms

The American journal of gastroenterology, 2000, Vol.95 (9), p.2457-2457

2000

Link zum Volltext

Verfügbarkeit prüfen

Cross-sectional analysis of renal function in black Americans with NIDDM

Diabetes care, 1990-11, Vol.13 (11), p.1186

1990

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 33

Suche als RSS-Feed

Aktive Filter

Zeitschrift / SerieMayo Clinic Proceedings

PublikationsformBuchkapitel

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(29)
Mit Volltextzugriff
(24)

Publikationsform

Artikel
(31)
magazinearticle
(2)

Sprache

Englisch
(33)
Japanisch
(4)

Erscheinungsjahr

n.n

Thema

Humans
(24)
Science & Technology
(20)
Life Sciences & Biomedicine
(19)
Biological And Medical Sciences
(16)
Female
(16)
Middle Aged
(16)
Male
(15)
Medical Sciences
(15)
Aged
(10)
Double-Blind Method
(10)
Adult
(9)
Treatment Outcome
(8)
Cardiology. Vascular System
(7)
Drug Therapy, Combination
(7)
Ezetimibe
(6)
Simvastatin - Administration & Dosage
(6)
Cardiovascular Disease
(5)
Cholesterol
(5)
Diabetes Mellitus, Type 2 - Physiopathology
(5)
General & Internal Medicine
(5)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Patient preference for once-weekly alendronate 70 mg versus once-daily alendronate 10 mg: A multicenter, randomized, open-label, crossover study

Once-weekly alendronate 70 mg and raloxifene 60 mg daily in the treatment of postmenopausal osteoporosis

Dose-comparison study of the combination of ezetimibe and simvastatin (Vytorin) versus atorvastatin in patients with hypercholesterolemia: The Vytorin Versus Atorvastatin (VYVA) Study

Early intensive vs a delayed conservative simvastatin strategy in patients with acute coronary syndromes: phase Z of the A to Z trial

Effectiveness and tolerability of simvastatin plus fenofibrate for combined hyperlipidemia (the SAFARI trial)

Rechallenge of patients who had discontinued alendronate therapy because of upper gastrointestinal symptoms

Efficacy and safety of ezetimibe co-administered with simvastatin compared with atorvastatin in adults with hypercholesterolemia

Effectiveness of the addition of ezetimibe to ongoing statin therapy in modifying lipid profiles and attaining low-density lipoprotein cholesterol goals in older and elderly patients: Subanalyses of data from a randomized, double-blind, placebo-controlled trial

Safety and efficacy of enoxaparin vs unfractionated heparin in patients with non-ST-segment elevation acute coronary syndromes who receive tirofiban and aspirin: a randomized controlled trial

Sequence variation in NPC1L1 and association with improved LDL-cholesterol lowering in response to ezetimibe treatment

Lipid altering-efficacy of ezetimibe co-administered with simvastatin compared with rosuvastatin: a meta-analysis of pooled data from 14 clinical trials

The rechallenge of patients who previously discontinued alendronate due to upper gastrointestinal symptoms

Effect on high-density lipoprotein cholesterol of maximum dose simvastatin and atorvastatin in patients with hypercholesterolemia: Results of the Comparative HDL Efficacy and Safety Study (CHESS)

Enoxaparin versus unfractionated heparin in patients treated with tirofiban, aspirin and an early conservative initial management strategy: results from the A phase of the A-to-Z trial

Dyslipidemia in Patients with Type 2 Diabetes. Relationships between Lipids, Kidney Disease and Cardiovascular Disease

Efficacy and tolerability of finasteride 1 mg in men aged 41 to 60 years with male pattern hair loss

Ezetimibe/Simvastatin Versus Atorvastatin for Patients Who Have Diabetes Mellitus and Hypercholesterolemia

A multicenter, randomized, double-blind clinical trial comparing the low-density lipoprotein cholesterol-lowering ability of lovastatin 10, 20, and 40 mg/d with fluvastatin 20 and 40 mg/d

1084-176 Efficacy of ezetimibe coadministered with simvastatin versus atorvastatin in patients with hypercholesterolemia

Effectiveness of simvastatin therapy in raising HDL-C in patients with type 2 diabetes and low HDL-C

Hyperfiltration in African-American patients with type 2 diabetes. Cross-sectional and longitudinal data

Dyslipidemia in patients with type 2 diabetes. Relationships between lipids, kidney disease and cardiovascular disease: Diabetes mellitus

861-2 Enoxaparin versus unfractionated heparin in patients treated with tirofiban, aspirin, and an early conservation initial management strategy: Results from the A phase of the A to Z trial

The rechallenge of patients who previously discontinued alendronate due to upper gastrointestinal symptoms

Cross-sectional analysis of renal function in black Americans with NIDDM

Aktive Filter

Suchergebnisse filtern